Form 4 for EQH Equitable Holdings, Inc.
Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-13 · accession 0001628280-25-006130 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-18 | 2025-02-13 | EQH | Lane Nick | See Remarks | A - Grant | $0.00 | +22.5K | 144.1K | +19% | $0 |
| DM | 2025-02-18 | 2025-02-14 | EQH | Lane Nick | See Remarks | S - Sale+OE | $55.24 | -25.0K | 148.8K | -14% | -$1.38M |
| D | 2025-02-18 | 2025-02-14 | EQH | Lane Nick | See Remarks | M - OptEx | $23.18 | +5,000 | 149.1K | +3% | +$115.9K |
| D | 2025-02-18 | 2025-02-14 | EQH | Lane Nick | See Remarks | M - OptEx | $0.00 | -5,000 | 69.4K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-13 | A | A | 22,506 | $0.00 | 144,135 | D | — | — | (F1) Grant of restricted stock units under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer upon vesting. The restricted stock units vest in three ratable annual installments beginning on February 28, 2026. Vested shares will be delivered to the reporting person within 30 days following the vesting date. (F2) Total includes Restricted Stock Units. |
| 2 | Common | Common Stock | 2025-02-14 | S | D | 19,000 | $55.29 | 124,135 | D | — | — | (F3) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024. (F7) This transaction was executed in multiple trades at prices ranging from $54.8700 to $55.7500. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes toprovide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Total includes Restricted Stock Units. |
| 3 | Common | Common Stock | 2025-02-14 | S | D | 1,000 | $54.27 | 143,135 | D | — | — | (F3) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024. (F6) This transaction was executed in multiple trades at prices ranging from $53.8500 to $54.8200. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes toprovide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Total includes Restricted Stock Units. |
| 4 | Common | Common Stock | 2025-02-14 | S | D | 4,700 | $55.29 | 144,135 | D | — | — | (F3) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024. (F5) This transaction was executed in multiple trades at prices ranging from $55.0000 to $55.6400. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes toprovide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Total includes Restricted Stock Units. |
| 5 | Common | Common Stock | 2025-02-14 | S | D | 300 | $54.26 | 148,835 | D | — | — | (F3) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024. (F4) This transaction was executed in multiple trades at prices ranging from $53.9800 to $54.8100. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Total includes Restricted Stock Units. |
| 6 | Common | Common Stock | 2025-02-14 | M | A | 5,000 | $23.18 | 149,135 | D | — | — | (F3) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024. (F2) Total includes Restricted Stock Units. |
| 7 | Derivative | Employee Stock Option (right to buy) | 2025-02-14 | M | D | 5,000 | $0.00 | 69,417 | D | $23.18 · — to 2030-02-26 | 5,000 Common Stock | (F3) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024. (F8) Grant of employee stock option under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. The options vest/vested in three installments beginning on February 26, 2021. |